Adaptin Bio: securities offering (amended)

Form: S-1/A
Filed: Jun 27, 2025, 3:37 pm ET
Importance: Routine
Accession: 0001213900-25-058957
Document: S-1/A
Exhibit 4.1: Form of pre-merger warrant issued to holders of 2023 bridge notes
Exhibit 4.2: Form of pre-merger warrant issued in connection with exchange notes
Exhibit 4.3: Form of placement agent warrant
Exhibit 4.4: Form of common a warrant
Exhibit 4.5: Form of common b warrant
Exhibit 10.1: Patent license agreement by and between centaur Bio and duke university…
Exhibit 10.2: First amendment to license agreement by and between centaur Bio and duke…
Exhibit 10.3: Sponsored research agreement by and between centaur Bio and duke university…
Exhibit 10.4: Advisory services agreement, dated as of February 11, 2025, by and between the…
Exhibit 10.5: Form of lock-up agreement
Exhibit 10.6: Form of indemnity agreement
Exhibit 10.7: Form of subscription agreement by and among the company and the parties thereto
Exhibit 10.8: Form of registration rights agreement, by and between the company and the…
Exhibit 10.9: 2025 equity incentive plan and form of award agreements
Exhibit 10.10: Executive employment agreement by and between the company and simon c. pedder…
Exhibit 10.11: Executive employment agreement by and between the company and michael j.…
Exhibit 10.12: Executive employment agreement by and between the company and timothy l.…
Exhibit 10.13: Executive employment agreement by and between the company and l. arthur hewitt,
Exhibit 10.14: Compensation agreement by and between Centaur Bio Inc. and simon pedder, dated…
Exhibit 10.15: Compensation agreement by and between Centaur Bio Inc. and Mac B Consulting LLC
Exhibit 10.16: Consulting agreement by and between Centaur Bio Inc. and Adamanteus LLC, dated…
Exhibit 10.17: Consulting agreement by and between the company and l. arthur hewitt, dated…

Not explained yet; the original is on EDGAR.

Securities offering (amended)

Similar companies

Same SIC code (2836) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

Abpro Holdings ABP public float $9M, Jun 30, 2025
BioCardia BCDA public float $10M, Jun 30, 2025
LeonaBio ATHA public float $10M, Jun 30, 2025
Brainstorm Cell Therapeutics BCLI public float $10M, Jun 30, 2025
Calidi Biotherapeutics CLDI public float $8M, Jun 30, 2025

Get an email when Adaptin Bio files

Similar companies